Diligence memo · auto-generated · as of July 2, 2026

Oprex Surgery (Baytown), L.P.

Oprex Surgery (Baytown), L.P. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Oprex Surgery (Baytown), L.P. operates in Other Health Care, based in Pearland.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Oprex Surgery (Baytown), L.P. has raised $3.0M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.3M on —.

Valuation (modeled)modeled

Provath models Oprex Surgery (Baytown), L.P. at approximately $4.3M (range $1.9M–$6.7M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.15× the median modeled value of Seed Other Health Care companies (1470 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

The last round was 3.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 55% of Other Health Care peers (5377 compared).

Modeled value ranks above 19% of those peers.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.